Minerva Neurosciences NERV
NASDAQ NERV
$2.49 -0.14 (-5.32%)
At close: Nov 10, 2026 · 4:00 PM EST

Minerva Neurosciences (NERV) Liabilities and Shareholders Equity (2013 - 2026)

Updated

Analysis

Minerva Neurosciences (NERV) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Minerva Neurosciences 124.09 Mn -188.49 Mn - 98.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 98.28 Mn
Jun 30, 2026 95.09 Mn
Mar 31, 2026 94.03 Mn
Dec 31, 2025 97.97 Mn
Sep 30, 2025 28.09 Mn
Jun 30, 2025 30.42 Mn
Mar 31, 2025 32.80 Mn
Dec 31, 2024 37.14 Mn
Sep 30, 2024 42.81 Mn
Jun 30, 2024 46.29 Mn
Mar 31, 2024 50.51 Mn
Dec 31, 2023 56.90 Mn
Sep 30, 2023 63.13 Mn
Jun 30, 2023 67.14 Mn
Mar 31, 2023 51.59 Mn
Dec 31, 2022 55.09 Mn
Sep 30, 2022 59.76 Mn
Jun 30, 2022 64.96 Mn
Mar 31, 2022 70.62 Mn
Dec 31, 2021 77.12 Mn
API Access

Minerva Neurosciences Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NERV&period=max&api_key=YOUR_API_KEY